HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potentiation of the NO-cGMP pathway and blood flow responses during dynamic exercise in healthy humans.

AbstractPURPOSE:
Previous work has shown nitric oxide (NO) contributes to ~15% of the hyperemic response to dynamic exercise in healthy humans. This NO-mediated vasodilation occurs, in part, via increases in intracellular cyclic guanosine monophosphate (cGMP), which is catabolized by phosphodiesterase. We sought to examine the effect of phosphodiesterase-5 (PDE-5) inhibition on forearm blood flow (FBF) responses to dynamic handgrip exercise in healthy humans and the role of NO. We hypothesized exercise hyperemia would be augmented by sildenafil citrate (SDF, PDE-5 inhibitor). We further hypothesized any effect of SDF on exercise hyperemia would be abolished with intra-arterial infusion of the NO synthase (NOS) inhibitor L-NG-monomethyl arginine (L-NMMA).
METHODS:
FBF (Doppler ultrasound) was assessed at rest and during 5 min of dynamic forearm handgrip exercise at 15% of maximal voluntary contraction under control (saline) conditions and during 3 experimental protocols: (1) oral SDF (n = 10), (2) intra-arterial L-NMMA (n = 20), (3) SDF and L-NMMA (n = 10). FBF responses to intra-arterial sodium nitroprusside (NTP, NO donor) were also assessed.
RESULTS:
FBF increased with exercise (p < 0.01). Intra-arterial infusion of L-NMMA resulted in a reduction in exercise hyperemia (17 ± 1 to 15 ± 1 mL/dL/min, p < 0.01). Although the hyperemic response to NTP was augmented by SDF (area under the curve: 41 ± 7 vs 61 ± 11 AU, p < 0.01), there was no effect of SDF on exercise hyperemia (p = 0.33).
CONCLUSIONS:
Despite improving NTP-mediated vasodilation, oral SDF failed to augment exercise hyperemia in young, healthy adults. These observations reflect a minor contribution of NO and the cGMP pathway during exercise hyperemia in healthy young humans.
AuthorsJacqueline K Limberg, Katherine R Malterer, J Mikhail Kellawan, William G Schrage, Brad W Wilkins, Wayne T Nicholson, John H Eisenach, Michael J Joyner, Timothy B Curry
JournalEuropean journal of applied physiology (Eur J Appl Physiol) Vol. 117 Issue 2 Pg. 237-246 (Feb 2017) ISSN: 1439-6327 [Electronic] Germany
PMID28013386 (Publication Type: Journal Article)
Chemical References
  • Enzyme Inhibitors
  • Nucleotides, Cyclic
  • Phosphodiesterase 5 Inhibitors
  • cyclic guanosine monophosphate-adenosine monophosphate
  • Nitroprusside
  • Nitric Oxide
  • Sildenafil Citrate
Topics
  • Adult
  • Blood Pressure (drug effects, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Exercise (physiology)
  • Female
  • Hand Strength (physiology)
  • Hemodynamics (drug effects, physiology)
  • Humans
  • Hyperemia (physiopathology)
  • Male
  • Nitric Oxide (metabolism)
  • Nitroprusside (pharmacology)
  • Nucleotides, Cyclic (metabolism)
  • Phosphodiesterase 5 Inhibitors (pharmacology)
  • Sildenafil Citrate (administration & dosage, pharmacology)
  • Vasodilation (drug effects, physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: